These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12004287)

  • 1. Stevens-Johnson syndrome in HIV patients treated with nevirapine: two case reports.
    Dodi F; Alessandrini A; Camera M; Gaffuri L; Morandi N; Pagano G
    AIDS; 2002 May; 16(8):1197-8. PubMed ID: 12004287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stevens-Johnson syndrome due to nevirapine].
    García Fernández D; García-Patos Briones V; Mollet Sánchez J; Castells Rodellas A
    Rev Clin Esp; 2000 Mar; 200(3):179-80. PubMed ID: 10804771
    [No Abstract]   [Full Text] [Related]  

  • 3. Nevirapine-associated Stevens-Johnson syndrome.
    Warren KJ; Boxwell DE; Kim NY; Drolet BA
    Lancet; 1998 Feb; 351(9102):567. PubMed ID: 9492778
    [No Abstract]   [Full Text] [Related]  

  • 4. Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.
    Tebruegge M; Ritz N; Connell T; Curtis N
    Pediatr Infect Dis J; 2008 Nov; 27(11):1041-2. PubMed ID: 18833024
    [No Abstract]   [Full Text] [Related]  

  • 5. Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.
    Mason AR; Cortes GY; Pollack RB
    Pediatr Dermatol; 2008; 25(1):128-9. PubMed ID: 18304177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Fagot JP; Mockenhaupt M; Bouwes-Bavinck JN; Naldi L; Viboud C; Roujeau JC;
    AIDS; 2001 Sep; 15(14):1843-8. PubMed ID: 11579247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report.
    Saka B; Akakpo AS; Bassowa A; Dapam AN; Mahamadou G; Teclessou JN; Mouhari-Toure A; Laouali AY; Mensah E; Kombaté K; Pitché P
    Ann Dermatol Venereol; 2018 Dec; 145(12):773-776. PubMed ID: 30301570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine-induced Stevens-Johnson syndrome in a mother and son.
    Liechty CA; Solberg P; Mwima G; Were W; Weidle PJ; Mermin J
    AIDS; 2005 Jun; 19(9):993-4. PubMed ID: 15905686
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver toxicity caused by nevirapine.
    González de Requena D; Núñez M; Jiménez-Nácher I; Soriano V
    AIDS; 2002 Jan; 16(2):290-1. PubMed ID: 11807315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine.
    Metry DW; Lahart CJ; Farmer KL; Hebert AA
    J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):354-7. PubMed ID: 11174414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exanthema in a patient infected with the human immunodeficiency virus after starting antiretroviral treatment].
    Palacios Muñoz R; Santos González J; Bosch García R; Márquez Solero M
    Rev Clin Esp; 2000 Nov; 200(11):635-6. PubMed ID: 11196597
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxic epidermal necrolysis associated with abacavir].
    Montero M; García-Gibert L; Giménez-Arnau AM; Knobel H
    Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):247. PubMed ID: 15826554
    [No Abstract]   [Full Text] [Related]  

  • 13. Stevens-Johnson syndrome in an HIV-infected patient.
    Blitz M; Spivack E; Kerpel SM; Freedman PD
    AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hepatic failure related to nevirapine treatment.
    Cattelan AM; Erne E; Salatino A; Trevenzoli M; Carretta G; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 1999 Aug; 29(2):455-6. PubMed ID: 10476768
    [No Abstract]   [Full Text] [Related]  

  • 15. Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.
    Otero MJ; Fuertes A; Sánchez R; Luna G
    AIDS; 1999 May; 13(8):1004-5. PubMed ID: 10371190
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of rash and discontinuation of nevirapine using two different escalating initial doses.
    Antón P; Soriano V; Jiménez-Nácher I; Rodriguez-Rosado R; Dona MC; Barreiro PM; González-Lahoz J
    AIDS; 1999 Mar; 13(4):524-5. PubMed ID: 10197383
    [No Abstract]   [Full Text] [Related]  

  • 17. Nevirapine-induced overlap stevens-johnson syndrome/toxic epidermal necrolysis.
    Wetterwald E; Le Cleach L; Michel C; David F; Revuz J
    Br J Dermatol; 1999 May; 140(5):980-2. PubMed ID: 10354056
    [No Abstract]   [Full Text] [Related]  

  • 18. Stevens-Johnson syndrome associated with nevirapine use in an HIV-positive pregnant woman: a case report.
    Agboghoroma CO; Uwaezuoke T; Jibrin PG
    West Afr J Med; 2010; 29(3):187-9. PubMed ID: 20665464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.
    Oberdorfer P; Washington CH; Jittamala P
    Pediatr Infect Dis J; 2008 Jun; 27(6):572. PubMed ID: 18458648
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipodystrophy associated with nevirapine-containing antiretroviral therapies.
    Aldeen T; Wells C; Hay P; Davidson F; Lau R
    AIDS; 1999 May; 13(7):865-7. PubMed ID: 10357391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.